Skip to main content
Dryad logo

Data from: Continuous glucose monitoring profiles in healthy non-diabetic participants: a multicenter prospective study

Citation

Shah, Viral N. et al. (2019), Data from: Continuous glucose monitoring profiles in healthy non-diabetic participants: a multicenter prospective study, Dryad, Dataset, https://doi.org/10.5061/dryad.h7d11cd

Abstract

Context: Use of continuous glucose monitoring (CGM) is increasing for insulin-requiring patients with diabetes. While data on glycemic profiles of healthy, non-diabetic individuals exists for older sensors, assessment of glycemic metrics with new generation CGM devices is lacking. Objective: To establish reference sensor glucose ranges in healthy, non-diabetic individuals across different age groups, using a current generation CGM sensor. Design: Multicenter, prospective study. Setting: 12 centers within the T1D Exchange Clinic Network. Patients or Participants: Non-pregnant, healthy, non-diabetic children and adults (age ≥6 years); with non-obese body mass index. Intervention: A blinded Dexcom G6 CGM, with once daily calibration, was worn for up to 10 days in each participant. Main Outcome Measure: CGM metrics of mean glucose, hyperglycemia, hypoglycemia, and glycemic variability. Results: 153 participants (age 7-80 years) were included in the analyses. Mean average glucose was 98-99 mg/dL (5.4-5.5 mmol/L) for all age groups except those over 60 years in whom mean average glucose was 104 mg/dL (5.8 mmol/L). The median % time between 70-140 mg/dL (3.9-7.8 mmol/L) was 96% (IQR 93%-98%). Mean within-individual coefficient of variation (CV) was 17±3%. Median time spent with glucose levels >140mg/dL was 2.1% (30 min/day) and <70 mg/dL (3.9 mmol/L) was 1.1% (15 min/day). Conclusion: By assessing across age groups in a healthy, non-diabetic population, normative sensor glucose data have been derived, and will be useful as a benchmark for future research studies.

Usage Notes

Location

United States